Cita APA

Fu, M., Maresh , E. L., Helguera, G. F., Kiyohara, M., Qin, y., Ashki, N., . . . Wadehra, M. (2014). Rationale and preclinical efficacy of a novel anti-EMP2 antibody for the treatment of invasive breast cancer. Web

Citación estilo Chicago

Fu, Maoyong, et al. Rationale and Preclinical Efficacy of a Novel Anti-EMP2 Antibody for the Treatment of Invasive Breast Cancer. 2014.

Cita MLA

Fu, Maoyong, et al. Rationale and Preclinical Efficacy of a Novel Anti-EMP2 Antibody for the Treatment of Invasive Breast Cancer. 2014.